English
-
15 Apr, 2025
Spago Nanomedical publishes the annual report for 2024
-
9 Apr, 2025
NOTICE TO ANNUAL GENERAL MEETING OF SPAGO NANOMEDICAL AB (PUBL)
-
20 Mar, 2025
Nomination committee’s proposal for a new chairman and composition of Spago Nanomedical’s board
-
4 Mar, 2025
Spago Nanomedical proceeds with increased dose in the phase I/IIa study Tumorad-01
-
6 Feb, 2025
Spago Nanomedical year-end report January-December, 2024
-
15 Jan, 2025
Spago Nanomedical article on SPAGOPIX-01 clinical results accepted for publication in Investigative Radiology
-
18 Dec, 2024
Second patient group successfully dosed in Spago Nanomedical’s Phase I/IIa study Tumorad-01
-
6 Nov, 2024
Spago Nanomedical interim report January-September 2024
-
21 Oct, 2024
Nomination committee appointed for Spago Nanomedical’s Annual General Meeting 2025
-
1 Oct, 2024
Spago Nanomedical in new phase with full focus on the Tumorad program